MSB

2.51%

97.0¢ mesoblast limited

Shorts very mostly right in the past. If they are at lowest...

First 1049 Last

Share
Profile

Follow
rakeshnirzari1

537 Posts.

54

02/08/24

11:41

Post #: 75042532
Share

Originally posted by vorzaw: ↑

hi folks,

See below today's short summary as of 26 July,

Some preliminary observations which might be of interest or useless to some:

1) As of 26 July, short position is sitting at a historically low range of 1.74% and ~30% reduction on shares shorted from previous month
2) 26 July also saw the price go down to ~1.13 after reaching 1.325 post BLA submission announcement.
3) this is does not appear to me to be a short attack, more like a pretty well executed trade from those who have long term understanding of nature of biotechs, including traders and long term investors on this forum. I note Reg did the same
4) I had pondered selling and re-buying at later price to increase share holding, but didnt. Alternatively could have banked over 150k profit and retained the same holdings buying in at current prices.
5) Clearly I am a crap trader, but recognise that all it takes is an unexpected positive announcement (Strat partnership, FDA CHF update, BLA approval for Rem ) and $150k would be peanuts in comparison to hopefully significant gains as risk is reduced over time. Happy to wait, as 6 months is nothing in the scheme of things
6) the level of FUD being spread is almost comical given its baseless nature. Prior to FDA advising MSB that the clinical data was sufficient for BLA submission, at least the rhetoric of nay sayers had to be considered to some extent.
7) I anticipate that in a couple of months the FOMO will be palpable and suggest for an sp that is much closer to the recent valuation suggestions, but will continue to keep an eye on short position.

GLTH

Not investment advice
V

Expand

Shorts very mostly right in the past. If they are at lowest level, that means, they are sure that its not worth it anymore and upside is almost guaranteed!! is this a fair conclusion?

MSB Price at posting: 99.3¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

GRX

GreenX picks up prospective copper project in Germany

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

Is oil undervalued?

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

WGX

Westgold sets its sights on top five producer status through merger with Karora

There are more pages in this discussion • 11 more messages in this thread...

First 1049 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 97.0¢		Change -0.025(2.51%)		Mkt cap ! $1.107B

Open	High	Low	Value	Volume
97.0¢	$1.01	96.5¢	$7.757M	7.884M

Buyers (Bids)

No.	Vol.	Price($)
10	274918	97.0¢

Sellers (Offers)

Price($)	Vol.	No.
97.5¢	974	1

View Market Depth

No.	Vol.	Price($)
10	274918	0.970
7	85827	0.965
14	252006	0.960
3	67909	0.955
25	222534	0.950

Price($)	Vol.	No.
0.975	974	1
0.980	45619	1
0.990	50389	3
0.995	45574	3
1.000	127030	3

Last trade - 16.10pm 02/08/2024 (20 minute delay)

MSB (ASX) Chart

Shorts very mostly right in the past. If they are at lowest...

GreenX picks up prospective copper project in Germany

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Venture to sniff out high-grade REE targets at Jupiter project, WA

Is oil undervalued?

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Westgold sets its sights on top five producer status through merger with Karora

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Shorts very mostly right in the past. If they are at lowest...

Top Stories

GreenX picks up prospective copper project in Germany

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Venture to sniff out high-grade REE targets at Jupiter project, WA

Is oil undervalued?

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Westgold sets its sights on top five producer status through merger with Karora

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News